Dyne Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.939; its P/E ratio is -6.46; Dyne Therapeutics is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -66.64M	$ -60.21M	$ -64.90M	$ -45.68M	$ -40.23M
EBITDA	$ -66.43M	$ -60.08M	$ -64.86M	$ -45.46M	$ -39.80M
Net Income Common Stockholders	$ -66.64M	$ -60.21M	$ -64.90M	$ -44.19M	$ -38.89M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 123.10M	$ 157.82M	$ 207.73M	$ 238.21M	$ 256.01M
Total Assets	$ 165.08M	$ 205.24M	$ 251.42M	$ 288.64M	$ 306.32M
Total Debt	$ 27.41M	$ 28.23M	$ 29.04M	$ 29.76M	$ 30.48M
Net Debt	$ -95.69M	$ -129.60M	$ -178.70M	$ -208.45M	$ -225.53M
Total Liabilities	$ 73.79M	$ 53.21M	$ 44.54M	$ 46.71M	$ 53.96M
Stockholders Equity	$ 91.29M	$ 152.04M	$ 206.88M	$ 241.94M	$ 252.36M
Cash Flow	-
Free Cash Flow	$ -35.09M	$ -50.77M	$ -55.92M	$ -47.15M	$ -29.71M
Operating Cash Flow	$ -35.01M	$ -50.60M	$ -55.67M	$ -46.92M	$ -29.19M
Investing Cash Flow	$ 26.20M	$ 12.82M	$ 17.23M	$ 27.06M	$ 19.24M
Financing Cash Flow	$ 147.00K	$ 454.00K	$ 24.91M	$ 28.82M	$ 37.20M

Currency in USD

Dyne Therapeutics Earnings and Revenue History

Income Statement >

Dyne Therapeutics Debt to Assets

Balance Sheet >

Dyne Therapeutics Cash Flow

Cash Flow >

Dyne Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing